Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Oprah Winfrey reveals weight loss secret
Oprah Winfrey reveals taking GLP-1 weight-loss drug made her realize what she got wrong about ‘thin people’
The media queen also confessed that she was reluctant to take a GLP-1 drug because she felt it was “the easy way out.” That changed after a special on weight loss with experts and clinicians that she taped in July 2023. The panel discussion left her with her “biggest aha moment” about the medication.
Oprah Winfrey Shares What She Learned About “Thin People” After Experience With Weight-Loss Drug
Oprah Winfrey recently detailed how taking weight loss drugs shifted her longtime mindset about what she described as “thin people.”
Novel obesity drug induces up to 22% weight loss with no safety concerns
A novel GLP-1 and amylin receptor agonist featured a safety profile similar to other incretin-based therapies and conferred a significant weight reduction compared with placebo, according to top-line results from a phase 1b/2a trial.
The Health Risks and Benefits of Weight-Loss Drugs
T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ways they affect the body—both helpful and harmful—beyond reducing weight. In report published in Nature Medicine,
Novo Nordisk spikes as novel obesity drug causes up to 22% of weight loss
Novo Nordisk (NVO) stock gains on promising Phase 1/2 data for the drugmaker's new weight loss drug amycretin. Read more here.
Not Just For Weight Loss: GLP-1 Drugs May Affect Addiction And Dementia Risk
Over 2 million people were included in new research to test these drugs against 175 different health outcomes.
Oprah Winfrey reveals how weight-loss drug helped her realize the truth about ‘thin people’
Oprah Winfrey says taking weight-loss medications like Ozempic and Wegovy challenged and helped her understand the truth about “thin people”,
Oprah Winfrey faces backlash for making bold claim about ‘thin people’ after taking weight-loss drug
"All these years I thought that thin people -- those people -- just had more willpower," Winfrey said on her podcast.
Oprah Winfrey says taking weight loss drugs has changed her opinion of ‘thin people’
Oprah Winfrey is opening up about the impact of taking weight loss drugs on her perspective of “thin people.” During a conversation with Dr Ania Jastreboff on The Oprah Podcast, the 70-year-old admitted that GLP-1 drugs like Ozempic and Wegovy had changed her opinion of thin people.
Oprah Winfrey Slammed for Claiming 'Thin People' Aren't Thinking About Food After Taking Weight-Loss Drug
Oprah Winfrey is opening up about her experience taking weight-loss drug GLP-1. While speaking to guest Dr. Ania Jastreboff on the Tuesday, January 21, episode of “The Oprah Podcast," the talk-show host spilled,
The Internet is Coming for Oprah Because of Her Comments About Thin People and Weight Loss Drugs
The media mogul is being criticized by some for statements she made about thin people on the latest episode of her podcast.
55m
on MSN
Novo Nordisk stock surges 7% after Ozempic maker’s latest weight loss drug shows promise
The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger ...
4d
on MSN
Popular GLP-1 medications may have health benefits that extend beyond weight loss and blood sugar control, a new study finds
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
7h
on MSN
Novo Nordisk reports 22% weight loss in early subcutaneous amycretin trial
Novo Nordisk on Friday announced early-stage trial results for its amycretin obesity drug for subcutaneous injection, saying ...
21h
Demand for loose skin surgery rises with GLP-1 weight loss meds
As GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro gain popularity, doctors are observing a surge in patients ...
The Washington Post
4d
Sweeping review suggests weight-loss drugs’ effect on 175 conditions
A study by the Department of Veterans Affairs on the relationship between
GLP-1 weight-loss
drugs and 175 diseases and conditions supports a lot of what scientists already suspected about ...
Hosted on MSN
47m
Hers' Weight Loss Offerings Range from a $165 Ozempic Alternative to Protein-Packed Shakes
That could be through habit-forming actions to help improve your daily movement, or by achieving your weight loss goals.
New Atlas
8h
Lose fat, not muscle: A booster of this protein could be all that's needed
If you're one of the 13% of American adults who has taken a GLP-1 drug for weight loss, you may know that while fat seemingly ...
The Express Tribune
6h
Gemma Collins reveals weight loss transformation using Mounjaro injections
Gemma Collins reveals weight loss with Mounjaro injections, showcasing a new look and expressing newfound confidence.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Ozempic
Oprah Winfrey
Novo Nordisk
Eli Lilly and Company
Wegovy
Feedback